Hudson Bay Capital Management’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-62,084
Closed -$111K – 1616
2026
Q1
$111K Buy
62,084
+17,028
+38% +$36.1K ﹤0.01% 1171
2025
Q4
$101K Buy
+45,056
New +$118K ﹤0.01% 1022
2025
Q3
– Sell
-29,887
Closed -$17.7K – 1594
2025
Q2
$17.7K Buy
+29,887
New +$23.3K ﹤0.01% 1315

Other funds holding PROK

Hudson Bay Capital Management's PROK Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of ProKidney (PROK) in Q2 2026, closing a stake of 62,084 shares — an estimated $111K sold.

Hudson Bay Capital Management first reported a position in PROK in Q2 2025 and held it in 3 quarters. The position peaked at $111K in Q1 2026. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining ProKidney position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 62,084 ProKidney shares in Q2 2026, an estimated $111K.
  • Hudson Bay Capital Management first reported a position in ProKidney in Q2 2025 and held it in 3 quarters.
  • Hudson Bay Capital Management's ProKidney position peaked at $111K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.